We strongly believe that early phase clinical trials can be designed to provide critical proof-of-concept data faster and more cost-efficient. Without compromising on quality, the INFECTA team takes pride in designing fit-for-purpose early phase clinical trials which aim to maximally derisk downstream clinical development.
We provide a wide range of services for the development of vaccines, therapeutics, antivirals and biologics. We use and develop various clinical research methodologies and are global leading experts on the controlled human infection models (CHIMs).
Emerging from the longstanding collaboration between five Dutch University Medical Centers and the Centre for Human Drug Research (CHDR), we have a strong legacy in early phase clinical research programs and a strong scientific orientation, including experience with CHIMs.
Company Details
- Employees
- 2
- Founded
- -
- Address
- The Most Pressing Medical Challenges? How Can Industry Leaders Align R&d Priorities With Patient Needs While Balancing Market Potential
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://infecta.org/
Infecta Questions
Infecta's website is https://infecta.org/
Infecta's LinkedIn profile is https://www.linkedin.com/company/infecta
Infecta has
2 employees.
View email and phone details for 2
employees at Infecta.
Infecta's industry is
Hospitals and Health Care
Infecta's categories are Hospitals and Health Care
Infecta's founding year is 2025
